Navigation Links
Ophthotech Enrolls Its First Patient in a Randomized, Controlled Phase II Study of E10030 in Macular Degeneration
Date:4/26/2010

PRINCETON, N.J., April 26 /PRNewswire/ -- Ophthotech Corp. ("Ophthotech"), a privately held biopharmaceutical company focused on developing ophthalmic therapies for back-of-the-eye diseases, today announced that the first patient has been enrolled in its Phase II randomized, controlled clinical trial of E10030, an anti-PDGF aptamer, in combination with Lucentis® for the treatment of wet age-related macular degeneration (AMD).  

The Phase II trial will assess the efficacy and safety of the combination treatment regimen with approximately 444 patients enrolled at sites in the U.S., Europe and Latin America. In a Phase I clinical study, 59 percent of patients treated with E10030 and Lucentis, an anti-VEGF agent, gained significant vision (3-line gain or better) 12 weeks after the start of therapy.  Notably, there was a mean decrease of 86% in the area of choroidal neovascularization (CNV) at 12 weeks.  In comparison, current standard of care utilizing monotherapy anti-VEGF treatment does not induce significant neovascular regression and results in 3-line or better visual gain in approximately one third of patients.

"With current standard of care, the majority of wet AMD patients do not achieve significant visual gain nor neovascular regression," said Samir Patel, MD, president and CEO of Ophthotech. "Combination therapy with E10030 demonstrates a significant advancement in the treatment of wet AMD.  The magnitude of neovascular regression noted in this Phase 1 study appears to be associated with a significant visual gain in the majority of these patients after only 12 weeks, a result not seen with anti-VEGF treatment alone."

Wet AMD is characterized by the
'/>"/>

SOURCE Ophthotech Corp.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Spectranetics Enrolls First Patient in PATENT Trial for the Treatment of Instent Restenosis
2. VIA Pharmaceuticals Enrolls First Patient in Phase 2 Clinical Trial to Measure Impact of VIA-2291 to Reduce Vascular Inflammation
3. Nventa Enrolls and Initiates Dosing of Final Cohort in HspE7 Phase 1 Cervical Dysplasia Trial
4. Micromet Enrolls First Patient in a Phase 1 Clinical Trial with MT110, the First BiTE Antibody for Treatment of Solid Tumors
5. Novagali Pharma Successfully Enrolls First Patient in U.S. Phase I Clinical Study with CORTIJECT(R) for Diabetic Macular Edema
6. Transdel Enrolls First Patient for Ketotransdel(TM) Phase 3 Clinical Trial
7. Uroplasty Enrolls First Patients in Urgent(R) PC Clinical Trial
8. HEALTHPOINT-Sponsored Venous Leg Ulcer Clinical Trial Enrolls First Subject for Second Phase II Study
9. S.C. Medical Home Pilot for Diabetes Enrolls 1,110
10. Curemark Enrolls First Patients in Phase III Clinical Trials for Autism Treatment
11. Facet Solutions Enrolls 100th Patient in US Pivotal IDE Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... Maine , Dec. 22, 2014  Mark ... analysis brief providing a summary of the 2015 ... plan enrollment trends.  According to ... for Planning and Evaluation, Department of Health and ... were enrolled in individual medical plans through the ...
(Date:12/19/2014)... N.J. , Dec. 19, 2014  In the Friday, December ... a 16-page supplement dedicated to Healthcare Information Technology (HIT) features Konica ... in Healthcare IT in partnership with several leading healthcare organizations. ... distributed across several major metropolitan markets, such as New ... DC / Baltimore , Minneapolis ...
(Date:12/19/2014)... , Dec. 19, 2014 Breckenridge Pharmaceutical, Inc. ... agreement with MSN Laboratories Pvt. Ltd. ( Hyderabad, ... to commercialize several new ANDAs.  Under the terms of ... products exclusively to Breckenridge for the U.S. market, and ... label.  Breckenridge and MSN have agreed to develop an ...
Breaking Medicine Technology:Insights into the Marketplace and Individual Market Growth 2USA Today Supplement Featuring Konica Minolta Focuses on Impact of Healthcare IT 2Breckenridge Pharmaceutical signs Multi-Product Generic Agreement with MSN Laboratories Pvt. Ltd. 2
... March 28, 2011 Quest Diagnostics Incorporated (NYSE: ... testing, information and services, announced today it has commenced ... Acquisition Corporation, for all of the outstanding shares of ... CRA ), one of the world,s pioneers in ...
... Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR ) ... difficile infection using National health insurance claims and ... 2, 2011 at the 21st Annual Scientific ... (SHEA).   (Logo:   http://photos.prnewswire.com/prnh/20090413/LA97352LOGO )Poster Presentation ...
Cached Medicine Technology:Quest Diagnostics Commences Tender Offer for Acquisition of Celera 2Quest Diagnostics Commences Tender Offer for Acquisition of Celera 3Optimer Pharmaceuticals Announces Presentation at Upcoming SHEA Annual Meeting Regarding Hospital CDI Patients at Risk of Recurrence and Mortality 2
(Date:12/22/2014)... Branch, TX (PRWEB) December 22, 2014 ... revolutionary work glove with many useful features. Customers of ... and can have the new gloves delivered to their ... work gear and hand tools that incorporate heavy duty ... Utility Magnetic Glove allows workers to store metal parts ...
(Date:12/22/2014)... (PRWEB) December 22, 2014 Christmas is days ... has a fast and easy solution that will please: the ... can be purchased from from $25 up to $350," says ... 100% customer satisfaction and a wide array of skin care ... fees and no expiration dates. , Gift delivery past ...
(Date:12/22/2014)... City, NY (PRWEB) December 22, 2014 ... as a 2014 Professional Woman of the Year. She ... healthcare. As the largest, most recognized networking organization of ... and profession, the National Association of Professional Women is ... nearly 300 Local Chapters. , Ms. Kreider is passionate ...
(Date:12/22/2014)... December 22, 2014 The ... professional development programs this month. Faculty have been ... on nurse educators fast-tracked for administrative leadership roles ... Development Program for Simulation Educators, featuring a curriculum ... of nursing education. , Twenty nurse educators ...
(Date:12/22/2014)... December 22, 2014 Parker & Sons, ... best in Arizona home contracting services reports a record ... its quality services in 2014. As a company that ... early 1970s, Parker and Sons is a business that ... company works side-by-side with other top quality companies in ...
Breaking Medicine News(10 mins):Health News:MagnoGrip Pro Utility Magnetic Gloves on Sale at TheHardwareCity.com 2Health News:National Association of Professional Women Announces Cheryl A. Kreider, President / CEO of Kreider Health Solutions, LLC, a 2014 Professional Woman of the Year 2Health News:NLN Leadership Institute Announces 2015 Cohorts 2Health News:NLN Leadership Institute Announces 2015 Cohorts 3Health News:Parker & Sons Reports A Record Number Of Favorable References With Regard To Its Quality Services In 2014 2Health News:Parker & Sons Reports A Record Number Of Favorable References With Regard To Its Quality Services In 2014 3
... Cielo experiences explosive growth in software-as-a-service customer base , ... ... LLC, a provider of healthcare software and web applications, announces revenue ... the calendar year 2008, Cielo grew its installed base of clinician ...
... announced today the launch of a redesigned and ... release of their FREE 2009 full-color industrial products ... and packed with information to make the shopping ... industrial products since 1948, Reid Supply focuses on ...
... Globus Medical, Inc., the largest privately held ... the introduction of the PATRIOT SIGNATURE(TM) TLIF Spacer ... Spacer is the latest addition to Globus Medical,s ... Care products. The SIGNATURE(TM) TLIF Spacer system includes ...
... Recall to Wholesale Level on Certain Products Expanded to Retail ... KV Pharmaceutical Company (NYSE: KVa ; KVb), ... a previously announced recall on certain products. The recall ... the wholesale level, but is now being expanded to the ...
... and INDIANAPOLIS, Feb. 3 The U.S. Food ... voted 9,to 0 that prasugrel, an investigational antiplatelet ... with acute coronary syndromes (ACS) managed with,an artery-opening ... Company, Limited, (TSE: 4568), and Eli Lilly and ...
... doubt as to safety, transparency of medical research, study ... parents are more likely than white parents to distrust ... frequently underrepresented in studies. , So conclude University of ... white) who brought their children to a primary-care clinic. ...
Cached Medicine News:Health News:Cielo MedSolutions Announces Strong Revenue Growth in 2008 2Health News:New Enhanced Web Site and Catalog from Reid Supply 2Health News:New Enhanced Web Site and Catalog from Reid Supply 3Health News:Globus Medical's SIGNATURE(TM) Spacer Designed for MILDER(TM) TLIF Procedures 2Health News:ETHEX Corporation Issues Voluntary Nationwide Recall 2Health News:Prasugrel Receives Unanimous Approval Recommendation from FDA Advisory Committee 2Health News:Prasugrel Receives Unanimous Approval Recommendation from FDA Advisory Committee 3Health News:Prasugrel Receives Unanimous Approval Recommendation from FDA Advisory Committee 4Health News:Prasugrel Receives Unanimous Approval Recommendation from FDA Advisory Committee 5Health News:Parental Distrust May Explain Lack of Black Children in Clinical Trials 2
The Durafuge 100 spins swing-out rotors at 4000 rpm and fixed-angle rotors at up to 6300 rpm....
... CO-Oximeter Control (Bayer 800 Series) is ... monitoring the performance of blood gas, ... 270 and 800 series) instrumentation. This ... Bayer 800 Rapidlab Series instruments in ...
Liquichek Blood Gas Plus CO-Oximeter Control (Radiometer) is a combination control for use in monitoring the performance of blood gas, ion-selective electrode, biosensor and CO-Oximeter (Radiometer) ...
Liquichek Blood Gas Plus EGL Control is an aqueous product used to monitor the measurement of pH, pCO2, pO2, electrolytes, glucose and lactate (lactic acid)....
Medicine Products: